APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fibromyalgia Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Fibromyalgia Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025193 pages

Choose your research edition.

Industry ResearchFibromyalgia Therapeutics Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Fibromyalgia Therapeutics Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Fibromyalgia Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fibromyalgia Therapeutics Drugs Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Fibromyalgia Therapeutics Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Fibromyalgia Therapeutics Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Fibromyalgia Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fibromyalgia Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fibromyalgia Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Fibromyalgia Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fibromyalgia Therapeutics Drugs include Eli Lilly, Pfizer, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP), Theravance, Switch Biotech, Pierre Fabre Mdicament, Merck Sharp and Dohme and Meiji Seika, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fibromyalgia Therapeutics Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fibromyalgia Therapeutics Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fibromyalgia Therapeutics Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fibromyalgia Therapeutics Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Fibromyalgia Therapeutics Drugs Segment by Company

Eli Lilly

Pfizer

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

Theravance

Switch Biotech

Pierre Fabre Mdicament

Merck Sharp and Dohme

Meiji Seika

Meda

Innovative Med Concepts

Forest Pharmaceuticals, Inc.

Daiichi Sankyo

Daiichi Sankyo

Boehringer Ingelheim GmbH

Actavis

Fibromyalgia Therapeutics Drugs Segment by Type

Cymbalta (Duloxetine)

Savella (Milnacipran)

Lyrica (Pregabalin)

Pancuronium

Others

Fibromyalgia Therapeutics Drugs Segment by Application

Hospital

Clinic

Others

Fibromyalgia Therapeutics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibromyalgia Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fibromyalgia Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibromyalgia Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fibromyalgia Therapeutics Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fibromyalgia Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fibromyalgia Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Fibromyalgia Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Fibromyalgia Therapeutics Drugs Industry Trends Table 2. Fibromyalgia Therapeutics Drugs Industry Drivers Table 3. Fibromyalgia Therapeutics Drugs Industry Opportunities and Challenges Table 4. Fibromyalgia Therapeutics Drugs Industry Restraints Table 5. Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Fibromyalgia Therapeutics Drugs Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Manufacturers Table 9. Global Fibromyalgia Therapeutics Drugs Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Fibromyalgia Therapeutics Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Fibromyalgia Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Fibromyalgia Therapeutics Drugs Manufacturers, Product Type & Application Table 13. Global Fibromyalgia Therapeutics Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Fibromyalgia Therapeutics Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Cymbalta (Duloxetine) Table 17. Major Manufacturers of Savella (Milnacipran) Table 18. Major Manufacturers of Lyrica (Pregabalin) Table 19. Major Manufacturers of Pancuronium Table 20. Major Manufacturers of Others Table 21. Global Fibromyalgia Therapeutics Drugs Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 22. Global Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 23. Global Fibromyalgia Therapeutics Drugs Sales by Type (2027-2032) & (Kg) Table 24. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2021-2026) Table 25. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2027-2032) Table 26. Global Fibromyalgia Therapeutics Drugs Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 27. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2026) & (Kg) Table 28. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2027-2032) & (Kg) Table 29. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Others Table 34. Global Fibromyalgia Therapeutics Drugs Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 35. Global Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 36. Global Fibromyalgia Therapeutics Drugs Sales by Application (2027-2032) & (Kg) Table 37. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2021-2026) Table 38. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2027-2032) Table 39. Global Fibromyalgia Therapeutics Drugs Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 40. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2026) & (Kg) Table 41. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2027-2032) & (Kg) Table 42. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Fibromyalgia Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 45. Global Fibromyalgia Therapeutics Drugs Sales by Region (2021-2026) & (Kg) Table 46. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2021-2026) Table 47. Global Fibromyalgia Therapeutics Drugs Sales Forecasted by Region (2027-2032) & (Kg) Table 48. Global Fibromyalgia Therapeutics Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Fibromyalgia Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 50. North America Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 51. North America Fibromyalgia Therapeutics Drugs Sales by Country (2027-2032) & (Kg) Table 52. Europe Fibromyalgia Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 53. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 54. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2027-2032) & (Kg) Table 55. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 57. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Country (2027-2032) & (Kg) Table 58. South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 59. South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 60. South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2027-2032) & (Kg) Table 61. Global Fibromyalgia Therapeutics Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2027-2032) Table 66. Eli Lilly Company Information Table 67. Eli Lilly Business Overview Table 68. Eli Lilly Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Eli Lilly Fibromyalgia Therapeutics Drugs Product Portfolio Table 70. Eli Lilly Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer Fibromyalgia Therapeutics Drugs Product Portfolio Table 75. Pfizer Recent Development Table 76. Zynerba Pharmaceuticals Company Information Table 77. Zynerba Pharmaceuticals Business Overview Table 78. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Portfolio Table 80. Zynerba Pharmaceuticals Recent Development Table 81. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Information Table 82. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview Table 83. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Portfolio Table 85. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development Table 86. Theravance Company Information Table 87. Theravance Business Overview Table 88. Theravance Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Theravance Fibromyalgia Therapeutics Drugs Product Portfolio Table 90. Theravance Recent Development Table 91. Switch Biotech Company Information Table 92. Switch Biotech Business Overview Table 93. Switch Biotech Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Switch Biotech Fibromyalgia Therapeutics Drugs Product Portfolio Table 95. Switch Biotech Recent Development Table 96. Pierre Fabre Mdicament Company Information Table 97. Pierre Fabre Mdicament Business Overview Table 98. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Portfolio Table 100. Pierre Fabre Mdicament Recent Development Table 101. Merck Sharp and Dohme Company Information Table 102. Merck Sharp and Dohme Business Overview Table 103. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Portfolio Table 105. Merck Sharp and Dohme Recent Development Table 106. Meiji Seika Company Information Table 107. Meiji Seika Business Overview Table 108. Meiji Seika Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Meiji Seika Fibromyalgia Therapeutics Drugs Product Portfolio Table 110. Meiji Seika Recent Development Table 111. Meda Company Information Table 112. Meda Business Overview Table 113. Meda Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Meda Fibromyalgia Therapeutics Drugs Product Portfolio Table 115. Meda Recent Development Table 116. Innovative Med Concepts Company Information Table 117. Innovative Med Concepts Business Overview Table 118. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Portfolio Table 120. Innovative Med Concepts Recent Development Table 121. Forest Pharmaceuticals, Inc. Company Information Table 122. Forest Pharmaceuticals, Inc. Business Overview Table 123. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Portfolio Table 125. Forest Pharmaceuticals, Inc. Recent Development Table 126. Daiichi Sankyo Company Information Table 127. Daiichi Sankyo Business Overview Table 128. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio Table 130. Daiichi Sankyo Recent Development Table 131. Daiichi Sankyo Company Information Table 132. Daiichi Sankyo Business Overview Table 133. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio Table 135. Daiichi Sankyo Recent Development Table 136. Boehringer Ingelheim GmbH Company Information Table 137. Boehringer Ingelheim GmbH Business Overview Table 138. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Portfolio Table 140. Boehringer Ingelheim GmbH Recent Development Table 141. Actavis Company Information Table 142. Actavis Business Overview Table 143. Actavis Fibromyalgia Therapeutics Drugs Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Actavis Fibromyalgia Therapeutics Drugs Product Portfolio Table 145. Actavis Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Fibromyalgia Therapeutics Drugs Distributors List Table 149. Fibromyalgia Therapeutics Drugs Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Fibromyalgia Therapeutics Drugs Product Image Figure 2. Global Fibromyalgia Therapeutics Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fibromyalgia Therapeutics Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Fibromyalgia Therapeutics Drugs Sales (2021-2032) & (Kg) Figure 5. Global Fibromyalgia Therapeutics Drugs Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Fibromyalgia Therapeutics Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Cymbalta (Duloxetine) Image Figure 9. Savella (Milnacipran) Image Figure 10. Lyrica (Pregabalin) Image Figure 11. Pancuronium Image Figure 12. Others Image Figure 13. Global Fibromyalgia Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Fibromyalgia Therapeutics Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 17. Global Fibromyalgia Therapeutics Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Fibromyalgia Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 23. Global Fibromyalgia Therapeutics Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 26. Global Fibromyalgia Therapeutics Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 29. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Canada Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Mexico Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 33. Europe Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 34. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 36. France Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 37. U.K. Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Italy Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Netherlands Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 40. Asia Pacific Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2021-2032) Figure 42. China Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Japan Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 44. South Korea Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Southeast Asia Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 46. India Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 47. Australia Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 48. South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 51. South Africa Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Saudi Arabia Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Turkey Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Argentina Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 55. UAE Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Egypt Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 57. Chile Fibromyalgia Therapeutics Drugs Sales and Growth Rate (2021-2032) & (Kg) Figure 58. Global Fibromyalgia Therapeutics Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Fibromyalgia Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Fibromyalgia Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Fibromyalgia Therapeutics Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Fibromyalgia Therapeutics Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Cymbalta (Duloxetine)
  • Savella (Milnacipran)
  • Lyrica (Pregabalin)
  • Pancuronium
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Eli Lilly
  • Pfizer
  • Zynerba Pharmaceuticals
  • Tonix Pharmaceuticals Holding Corp. (TNXP)
  • Theravance
  • Switch Biotech
  • Pierre Fabre Mdicament
  • Merck Sharp and Dohme
  • Meiji Seika
  • Meda
  • Innovative Med Concepts
  • Forest Pharmaceuticals, Inc.
  • Daiichi Sankyo
  • Daiichi Sankyo
  • Boehringer Ingelheim GmbH
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fibromyalgia Therapeutics Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fibromyalgia Therapeutics Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Fibromyalgia Therapeutics Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Fibromyalgia Therapeutics Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Fibromyalgia Therapeutics Drugs Market Dynamics
  1. 2.1 Fibromyalgia Therapeutics Drugs Industry Trends
  2. 2.2 Fibromyalgia Therapeutics Drugs Industry Drivers
  3. 2.3 Fibromyalgia Therapeutics Drugs Industry Opportunities and Challenges
  4. 2.4 Fibromyalgia Therapeutics Drugs Industry Restraints
3 Fibromyalgia Therapeutics Drugs Market by Manufacturers
  1. 3.1 Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Fibromyalgia Therapeutics Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Fibromyalgia Therapeutics Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Fibromyalgia Therapeutics Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fibromyalgia Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Fibromyalgia Therapeutics Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Fibromyalgia Therapeutics Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fibromyalgia Therapeutics Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fibromyalgia Therapeutics Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fibromyalgia Therapeutics Drugs Tier 1, Tier 2, and Tier 3
4 Fibromyalgia Therapeutics Drugs Market by Type
  1. 4.1 Fibromyalgia Therapeutics Drugs Type Introduction
  2. 4.1.1 Cymbalta (Duloxetine)
  3. 4.1.2 Savella (Milnacipran)
  4. 4.1.3 Lyrica (Pregabalin)
  5. 4.1.4 Pancuronium
  6. 4.1.5 Others
  7. 4.2 Global Fibromyalgia Therapeutics Drugs Sales by Type
  8. 4.2.1 Global Fibromyalgia Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Fibromyalgia Therapeutics Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Fibromyalgia Therapeutics Drugs Revenue by Type
  12. 4.3.1 Global Fibromyalgia Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2021-2032)
5 Fibromyalgia Therapeutics Drugs Market by Application
  1. 5.1 Fibromyalgia Therapeutics Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Fibromyalgia Therapeutics Drugs Sales by Application
  6. 5.2.1 Global Fibromyalgia Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fibromyalgia Therapeutics Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Fibromyalgia Therapeutics Drugs Revenue by Application
  10. 5.3.1 Global Fibromyalgia Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2021-2032)
6 Global Fibromyalgia Therapeutics Drugs Sales by Region
  1. 6.1 Global Fibromyalgia Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fibromyalgia Therapeutics Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Fibromyalgia Therapeutics Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Fibromyalgia Therapeutics Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fibromyalgia Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Fibromyalgia Therapeutics Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Fibromyalgia Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Fibromyalgia Therapeutics Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Fibromyalgia Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Fibromyalgia Therapeutics Drugs Revenue by Region
  1. 7.1 Global Fibromyalgia Therapeutics Drugs Revenue by Region
  2. 7.1.1 Global Fibromyalgia Therapeutics Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Fibromyalgia Therapeutics Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Fibromyalgia Therapeutics Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Fibromyalgia Therapeutics Drugs Revenue (2021-2032)
  8. 7.2.2 North America Fibromyalgia Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Fibromyalgia Therapeutics Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Fibromyalgia Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eli Lilly
  2. 8.1.1 Eli Lilly Company Information
  3. 8.1.2 Eli Lilly Business Overview
  4. 8.1.3 Eli Lilly Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eli Lilly Fibromyalgia Therapeutics Drugs Product Portfolio
  6. 8.1.5 Eli Lilly Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Fibromyalgia Therapeutics Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Zynerba Pharmaceuticals
  14. 8.3.1 Zynerba Pharmaceuticals Company Information
  15. 8.3.2 Zynerba Pharmaceuticals Business Overview
  16. 8.3.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Portfolio
  18. 8.3.5 Zynerba Pharmaceuticals Recent Developments
  19. 8.4 Tonix Pharmaceuticals Holding Corp. (TNXP)
  20. 8.4.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Information
  21. 8.4.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
  22. 8.4.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Portfolio
  24. 8.4.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments
  25. 8.5 Theravance
  26. 8.5.1 Theravance Company Information
  27. 8.5.2 Theravance Business Overview
  28. 8.5.3 Theravance Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Theravance Fibromyalgia Therapeutics Drugs Product Portfolio
  30. 8.5.5 Theravance Recent Developments
  31. 8.6 Switch Biotech
  32. 8.6.1 Switch Biotech Company Information
  33. 8.6.2 Switch Biotech Business Overview
  34. 8.6.3 Switch Biotech Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Switch Biotech Fibromyalgia Therapeutics Drugs Product Portfolio
  36. 8.6.5 Switch Biotech Recent Developments
  37. 8.7 Pierre Fabre Mdicament
  38. 8.7.1 Pierre Fabre Mdicament Company Information
  39. 8.7.2 Pierre Fabre Mdicament Business Overview
  40. 8.7.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Portfolio
  42. 8.7.5 Pierre Fabre Mdicament Recent Developments
  43. 8.8 Merck Sharp and Dohme
  44. 8.8.1 Merck Sharp and Dohme Company Information
  45. 8.8.2 Merck Sharp and Dohme Business Overview
  46. 8.8.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Portfolio
  48. 8.8.5 Merck Sharp and Dohme Recent Developments
  49. 8.9 Meiji Seika
  50. 8.9.1 Meiji Seika Company Information
  51. 8.9.2 Meiji Seika Business Overview
  52. 8.9.3 Meiji Seika Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Meiji Seika Fibromyalgia Therapeutics Drugs Product Portfolio
  54. 8.9.5 Meiji Seika Recent Developments
  55. 8.10 Meda
  56. 8.10.1 Meda Company Information
  57. 8.10.2 Meda Business Overview
  58. 8.10.3 Meda Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Meda Fibromyalgia Therapeutics Drugs Product Portfolio
  60. 8.10.5 Meda Recent Developments
  61. 8.11 Innovative Med Concepts
  62. 8.11.1 Innovative Med Concepts Company Information
  63. 8.11.2 Innovative Med Concepts Business Overview
  64. 8.11.3 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Portfolio
  66. 8.11.5 Innovative Med Concepts Recent Developments
  67. 8.12 Forest Pharmaceuticals, Inc.
  68. 8.12.1 Forest Pharmaceuticals, Inc. Company Information
  69. 8.12.2 Forest Pharmaceuticals, Inc. Business Overview
  70. 8.12.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Portfolio
  72. 8.12.5 Forest Pharmaceuticals, Inc. Recent Developments
  73. 8.13 Daiichi Sankyo
  74. 8.13.1 Daiichi Sankyo Company Information
  75. 8.13.2 Daiichi Sankyo Business Overview
  76. 8.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio
  78. 8.13.5 Daiichi Sankyo Recent Developments
  79. 8.14 Daiichi Sankyo
  80. 8.14.1 Daiichi Sankyo Company Information
  81. 8.14.2 Daiichi Sankyo Business Overview
  82. 8.14.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio
  84. 8.14.5 Daiichi Sankyo Recent Developments
  85. 8.15 Boehringer Ingelheim GmbH
  86. 8.15.1 Boehringer Ingelheim GmbH Company Information
  87. 8.15.2 Boehringer Ingelheim GmbH Business Overview
  88. 8.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Portfolio
  90. 8.15.5 Boehringer Ingelheim GmbH Recent Developments
  91. 8.16 Actavis
  92. 8.16.1 Actavis Company Information
  93. 8.16.2 Actavis Business Overview
  94. 8.16.3 Actavis Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Actavis Fibromyalgia Therapeutics Drugs Product Portfolio
  96. 8.16.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fibromyalgia Therapeutics Drugs Value Chain Analysis
  2. 9.1.1 Fibromyalgia Therapeutics Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fibromyalgia Therapeutics Drugs Production Mode & Process
  6. 9.2 Fibromyalgia Therapeutics Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fibromyalgia Therapeutics Drugs Distributors
  9. 9.2.3 Fibromyalgia Therapeutics Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst